ZA201302585B - Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodine using a dosing algorithm to provide analgesia - Google Patents
Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodine using a dosing algorithm to provide analgesiaInfo
- Publication number
- ZA201302585B ZA201302585B ZA2013/02585A ZA201302585A ZA201302585B ZA 201302585 B ZA201302585 B ZA 201302585B ZA 2013/02585 A ZA2013/02585 A ZA 2013/02585A ZA 201302585 A ZA201302585 A ZA 201302585A ZA 201302585 B ZA201302585 B ZA 201302585B
- Authority
- ZA
- South Africa
- Prior art keywords
- administration
- oxycodine
- opioid
- morphine
- oral
- Prior art date
Links
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title 2
- 230000036592 analgesia Effects 0.000 title 1
- 238000011260 co-administration Methods 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960005181 morphine Drugs 0.000 title 1
- 238000011269 treatment regimen Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/881,677 US7923453B1 (en) | 2009-10-14 | 2010-09-14 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
US12/881,728 US8012990B2 (en) | 2009-10-14 | 2010-09-14 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
US13/185,016 US8222267B2 (en) | 2009-10-14 | 2011-07-18 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
PCT/US2011/051577 WO2012037239A1 (en) | 2010-09-14 | 2011-09-14 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201302585B true ZA201302585B (en) | 2014-05-28 |
Family
ID=44903337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2013/02585A ZA201302585B (en) | 2010-09-14 | 2013-04-10 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodine using a dosing algorithm to provide analgesia |
Country Status (7)
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN603895A0 (en) | 1995-10-19 | 1995-11-09 | University Of Queensland, The | Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids |
US20050053659A1 (en) | 2003-09-10 | 2005-03-10 | Pace Gary W. | Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness |
AU2009203070A1 (en) * | 2008-05-20 | 2009-12-10 | Qrxpharma Limited | Dual opioid pain therapy |
US7923453B1 (en) * | 2009-10-14 | 2011-04-12 | QRxPharma Ltd. | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
US8012990B2 (en) * | 2009-10-14 | 2011-09-06 | QRxPharma Ltd. | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia |
US20170123700A1 (en) | 2015-11-03 | 2017-05-04 | Samsung Electronics Co., Ltd. | Io redirection methods with cost estimation |
-
2011
- 2011-09-14 CN CN2011800545718A patent/CN103415291A/zh active Pending
- 2011-09-14 EP EP11776929.9A patent/EP2616075A1/en not_active Withdrawn
- 2011-09-14 AU AU2011302137A patent/AU2011302137A1/en not_active Abandoned
- 2011-09-14 JP JP2013529296A patent/JP2013537232A/ja active Pending
- 2011-09-14 WO PCT/US2011/051577 patent/WO2012037239A1/en active Application Filing
- 2011-09-14 CA CA2811285A patent/CA2811285A1/en not_active Abandoned
-
2013
- 2013-04-10 ZA ZA2013/02585A patent/ZA201302585B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2616075A1 (en) | 2013-07-24 |
CN103415291A (zh) | 2013-11-27 |
WO2012037239A1 (en) | 2012-03-22 |
AU2011302137A1 (en) | 2013-05-02 |
JP2013537232A (ja) | 2013-09-30 |
CA2811285A1 (en) | 2012-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272501A (en) | Oral administration forms of bendamustine and their medical use | |
HRP20180436T1 (hr) | Upotreba amisulprida u liječenju mučnine i povraćanja uzrokovanih opijatima | |
EP2406765A4 (en) | DEVICE FOR ADMINISTERING A MEDICAMENT TO A PATIENT WITH RESTRICTED PATIENT-SIDED ACCESS TO THE MEDICAMENT IN THE CASE OF CONTRAINDICATIONS AND APPLICATION METHOD THEREFOR | |
IL221166A0 (en) | System and method for administering medicaments to a patient | |
EP2593039A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
EP2533834A4 (en) | APPARATUS FOR MEDICAMENT ADMINISTRATION | |
NZ597378A (en) | Treatment of multiple sclerosis with laquinimod | |
AP3155A (en) | Methods of administering pirfenidone therapy | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
EP2411083A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
EP2640450A4 (en) | DEVICES FOR DELIVERING A MEDICAMENT AND METHOD FOR TREATING PAIN | |
EP2768571A4 (en) | MEDICAL ACTIVE COMPOSITION DEVICE | |
EP2552439A4 (en) | METHOD FOR INCREASING AN ACTIVE EXTRACTION AND THE EFFICACY OF THERAPY AGENTS | |
PT2588090T (pt) | Formas de dosagem oral farmacêuticas compreendendo dabigatrano etexilato e os seus sais farmaceuticamente aceitáveis | |
IN2014KN00996A (enrdf_load_stackoverflow) | ||
ZA201205441B (en) | Dental strip for administration of oral treatment | |
IL222245A0 (en) | Use of ventricular enlargement rate in intravenous immunoglobulin treatment of alzheimer's disease | |
NZ719087A (en) | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome | |
EP2765971A4 (en) | BAG AND METHOD FOR INTRAVENOUS OR INTRAKORPOROUS ADMINISTRATION OF MEDICAL SOLUTIONS TO A PATIENT | |
IL233266A0 (en) | Methods for the treatment and prevention of opioid-induced constipation using oral compositions of methylnaltrexone | |
ZA201302585B (en) | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodine using a dosing algorithm to provide analgesia | |
FR2998801B1 (fr) | Ensemble a usage medical pour l'administration d'un produit a un patient | |
WO2011095801A3 (en) | Liquid pharmaceutical composition for buccal administration comprising morphine | |
SI2585051T2 (sl) | Farmacevtske oralne odmerne oblike,ki obsegajo lerkanidipin in enalapril in njune farmacevtsko sprejemljive soli | |
IL213770A (en) | Use of Fibert to prepare a drug to treat sleep apnea |